{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-114571","form_type":"8-K","ticker":"PCRX","cik":"0001396814","company_name":"Pacira BioSciences, Inc.","filed_at":"2026-10-08T13:24:36+00:00","discovered_at":"2026-10-08T13:26:00.129146+00:00","generated_at":"2026-10-12T15:35:09.624725+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Viatris to acquire Pacira BioSciences for $36.50/share cash, $1.65B equity value","bullets":["Viatris agreed to acquire Pacira for $36.50/share in cash, aggregate equity value $1.65B; tender offer to commence within 15 business days.","Pacira generated approximately $746M total revenue and approximately $177M adjusted EBITDA for the last twelve months ended June 30, 2026.","Deal adds EXPAREL (bupivacaine liposome) and ZILRETTA (triamcinolone acetonide) non-opioid pain products; expected close by end of 2026.","Viatris expects immediate accretion to guidance metrics; funded primarily from excess cash with remainder short-term borrowings; minimal impact on gross leverage ratio.","Pacira would pay $62.0M termination fee if it accepts a superior offer; merger under Delaware Section 251(h), no shareholder vote required."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-114571","json":"https://secwatch.observer/filing/0001104659-26-114571.json","markdown":"https://secwatch.observer/filing/0001104659-26-114571.md","text":"https://secwatch.observer/filing/0001104659-26-114571.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1396814/000110465926114571/0001104659-26-114571-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1396814/000110465926114571/tm2627240d2_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T15:35:09.624725+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}